PBPH Short Volume

Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $11.2M, listed on NASDAQ, carrying a beta of 0.09 to the broader market. The Portfolio Building Block World Pharma and Biotech Index ETF seeks to provide investors with targeted exposure to the global pharmaceutical and biotechnology industries, two of the most dynamic and innovation-driven sectors in healthcare. Led by Charles Alan Ragauss, public since 2025-11-25.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-06-01
Short Volume
837
Total Volume
78.4K
Short %
1.07%
30-Day Avg Short %
15.37%

Showing 30 days of FINRA short volume data for Portfolio Building Block World Pharma and Biotech Index ETF.

Learn how short volume is reported and how to read the data →

Frequently asked PBPH short volume questions

What is the daily PBPH short volume?
As of Jun 1, 2026, Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) short volume is 837 shares against 78.4K total reported volume, or 1.07% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is PBPH short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does PBPH short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.